These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32923117)

  • 21. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
    Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
    J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins.
    Safar HA; Mustafa AS; Amoudy HA; El-Hashim A
    PLoS One; 2020; 15(2):e0228381. PubMed ID: 32027660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfer of IFNgamma-depleted CD4(+) T cells together with CD8(+) T cells leads to rejection of murine kidney sarcoma in mice.
    Klugewitz K; Scheffold A; Radbruch A; Hamann A
    Int J Cancer; 2000 Sep; 87(5):673-9. PubMed ID: 10925361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition.
    Gorbachev AV; DiIulio NA; Fairchild RL
    J Immunol; 2001 Jul; 167(1):156-62. PubMed ID: 11418644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism between CpG-containing oligodeoxynucleotides and IL-2 causes dramatic enhancement of vaccine-elicited CD8+ T cell responses.
    Kochenderfer JN; Chien CD; Simpson JL; Gress RE
    J Immunol; 2006 Dec; 177(12):8860-73. PubMed ID: 17142789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
    Jackson RJ; Worley M; Trivedi S; Ranasinghe C
    Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
    Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
    Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.
    Jarnicki AG; Conroy H; Brereton C; Donnelly G; Toomey D; Walsh K; Sweeney C; Leavy O; Fletcher J; Lavelle EC; Dunne P; Mills KH
    J Immunol; 2008 Mar; 180(6):3797-806. PubMed ID: 18322186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses.
    Sharma S; Zhu L; Yang SC; Zhang L; Lin J; Hillinger S; Gardner B; Reckamp K; Strieter RM; Huang M; Batra RK; Dubinett SM
    J Immunol; 2005 Jul; 175(2):813-9. PubMed ID: 16002678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive effect of therapeutic antibiotic regimen on antipneumococcal Th1/Th17 responses in neonatal mice.
    Shekhar S; Brar NK; Petersen FC
    Pediatr Res; 2023 Mar; 93(4):818-826. PubMed ID: 35778498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells.
    Piccotti JR; Chan SY; Li K; Eichwald EJ; Bishop DK
    J Immunol; 1997 Jan; 158(2):643-8. PubMed ID: 8992979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine.
    Marshall DJ; Rudnick KA; McCarthy SG; Mateo LR; Harris MC; McCauley C; Snyder LA
    Vaccine; 2006 Jan; 24(3):244-53. PubMed ID: 16135392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells.
    Choi HG; Kim WS; Back YW; Kim H; Kwon KW; Kim JS; Shin SJ; Kim HJ
    Eur J Immunol; 2015 Jul; 45(7):1957-71. PubMed ID: 25907170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
    Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
    Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.